Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation

Benjamin Miao, Adrian V. Hernandez, Yuani M. Roman, Mark J. Alberts, Craig I. Coleman, William L. Baker

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background: There is a paucity of contemporary data assessing the implications of atrial fibrillation (AF) on major adverse cardiovascular events (MACE) in patients with or at high-risk for atherosclerotic disease managed in routine practice. Hypothesis: We sought to evaluate the 4-year incidence of MACE in patients with or at risk of atherosclerotic disease in the presence of AF. Methods: Using US MarketScan data, we identified AF patients ≥45 years old with billing codes indicating established coronary artery disease, cerebrovascular disease, or peripheral artery disease or the presence of ≥3 risk factors for atherosclerotic disease from January 1, 2013 to December 31, 2013 with a minimum of 4-years of available follow-up. We calculated the 4-year incidence of MACE (cardiovascular death or hospitalization with a primary billing code for myocardial infarction or ischemic stroke). Patients were further stratified by CHA 2DS 2-VASc score and oral anticoagulation (OAC) use at baseline. Results: We identified 625,951 patients with 4-years of follow-up, of which 77,752 (12.4%) had comorbid AF. The median (25%, 75% range) CHA 2DS 2-VASc score was 4 (3, 5) and 64% of patients received an OAC at baseline. The incidence of MACE increased as CHA 2DS 2-VASc scores increased (P-interaction<.0001 for all). AF patients receiving an OAC were less likely to experience MACE (8.9% vs 11.6%, P <.0001) including ischemic stroke (5.4% vs 6.7%, P <.0001). Conclusion: Comorbid AF carries a substantial risk of MACE in patients with or at risk of atherosclerotic disease. MACE risk increases with higher CHA 2DS 2-VASc scores and is more likely in patients without OAC.

Original languageAmerican English
Pages (from-to)524-531
Number of pages8
JournalClinical Cardiology
Volume43
Issue number5
DOIs
StatePublished - 1 May 2020

Keywords

  • atrial fibrillation
  • established atherosclerotic disease
  • major adverse cardiovascular events

Fingerprint

Dive into the research topics of 'Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation'. Together they form a unique fingerprint.

Cite this